Nasdaq: TSHA
Taysha Gene Therapies insiders
The officers, directors and 10% owners of Taysha Gene Therapies, Inc. who hold the most stock, valued at the live TSHA price.
$3.77
TSHA today −$220K (−5.51%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their TSHA stock
- $150M
- Market value
- $1.23B
- Held by ranked insiders
- 12.2%
Insiders by value of TSHA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Paul B. Manning | 10% owner | 22,920,985 | $86.4M | 7.03% | 663rd |
| 2 | R.A. Session II | 10% owner | 9,012,837 | $34.0M | 2.76% | 3424th |
| 3 | Sean P. Nolan | Chief Executive Officer | 4,443,802 | $16.8M | 1.36% | 5403rd |
| 4 | John A. Stalfort III | Director | 2,060,849 | $7.8M | 0.63% | 10054th |
| 5 | Kamran Alam | CHIEF FINANCIAL OFFICER | 1,442,131 | $5.4M | 0.44% | 13657th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Taysha Gene Therapies; see each profile for the filing.